Myeloid Neoplasms - 10/08/17
Doi : 10.1016/j.cll.2017.05.005
Antonio Subtil, MD, MBA a, b, ⁎ 
a Department of Dermatology, Yale Dermatopathology Laboratory, 15 York Street, LMP5031, New Haven, CT 06520, USA
b Department of Pathology, Yale Dermatopathology Laboratory, 15 York Street, LMP5031, New Haven, CT 06520, USA
∗Department of Dermatology, Yale Dermatopathology Laboratory, 15 York Street, LMP5031, New Haven, CT 06520.Department of DermatologyYale Dermatopathology Laboratory15 York StreetLMP5031New HavenCT06520
Résumé |
The classification of myeloid neoplasms has undergone major changes and currently relies heavily on genetic abnormalities. Cutaneous manifestations of myeloid neoplasms may be the presenting sign of underlying bone marrow disease. Dermal infiltration by neoplastic cells may occur in otherwise normal skin or in sites of cutaneous inflammation. Leukemia cutis occasionally precedes evidence of blood and/or bone marrow involvement (aleukemic leukemia cutis).
Le texte complet de cet article est disponible en PDF.Keywords : Myeloid, Neoplasms, Skin, Leukemia, Cutis, Acute, Chronic, Myelomonocytic
Plan
| Disclosure: No conflicts of interest or financial relationships. |
© 2017
Elsevier Inc. Tous droits réservés.
Vol 37 - N° 3
P. 575-585 - septembre 2017 Retour au numéro
Article précédent
- Primary Cutaneous B-cell Lymphomas
- Charity B. Hope, Laura B. Pincus
- Cutaneous Sweat Gland Carcinomas with Basaloid Differentiation : An Update with Emphasis on Differential Diagnoses
- Katharina Flux, Thomas Brenn
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?